Literature DB >> 9094677

Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16.

I Melero1, M C Singhal, P McGowan, H S Haugen, J Blake, K E Hellstrom, G Yang, C H Clegg, L Chen.   

Abstract

Certain human papillomaviruses (HPV) have been implicated in the etiology of cervical malignancies, and the E7 and E6 gene products of HPV type 16 are frequently expressed in these lesions. However, cytolytic T-lymphocyte (CTL)-mediated responses to HPV are rarely detectable in patients with cervical cancer. To examine whether the T-cell response is deficient during the HPV-induced transformation, we produced lines of transgenic (Tg) mice that expressed the E6 and E7 oncogenes in keratinized epithelia. The mice developed severe hypertrophy of all keratinized epithelia, but no malignancies were observed. Although epithelial cells from Tg mice could present at least an E7-encoded CTL epitope (E7 49-57), CTLs from these mice were neither primed to nor made tolerant of this epitope. No quantitative or qualitative differences were seen in the CTL responses of the Tg mice compared to those of their littermates following immunization with the peptide E7 49-57. Immunization of Tg mice with the E7 49-57 peptide protected them against a subcutaneous challenge with tumor cells expressing a transfected E7 gene, yet the skin was unaffected, although the cultured skin epithelial cells from Tg mice expressed E7. Our results suggest that the Tg mice were immunologically ignorant of HPV oncoproteins with respect to a CTL response and that a similar type of ignorance may explain why HPV-associated cervical cancer cells can escape immunological destruction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094677      PMCID: PMC191552     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.

Authors:  K Falk; O Rötzschke; S Stevanović; G Jung; H G Rammensee
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

Review 2.  The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.

Authors:  R Moll; W W Franke; D L Schiller; B Geiger; R Krepler
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

Review 3.  Human papillomaviruses and carcinomas.

Authors:  D A Galloway; J K McDougall
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

4.  Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.

Authors:  L P Chen; E K Thomas; S L Hu; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

5.  Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.

Authors:  M B Oldstone; M Nerenberg; P Southern; J Price; H Lewicki
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

6.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

Review 7.  Role of the human papillomaviruses in human cancer.

Authors:  P M Howley
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

8.  Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice.

Authors:  G Kondoh; Y Murata; K Aozasa; M Yutsudo; A Hakura
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen.

Authors:  G Soldevila; T Geiger; R A Flavell
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

10.  Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells.

Authors:  K Seedorf; T Oltersdorf; G Krämmer; W Röwekamp
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

View more
  22 in total

1.  Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28.

Authors:  A J Johnson; M K Njenga; M J Hansen; S T Kuhns; L Chen; M Rodriguez; L R Pease
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Anatomical and cellular requirements for the activation and migration of virus-specific CD8+ T cells to the brain during Theiler's virus infection.

Authors:  Yanice V Mendez-Fernandez; Michael J Hansen; Moses Rodriguez; Larry R Pease
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 3.  The many sounds of T lymphocyte silence.

Authors:  Ignacio Melero; Ainhoa Arina; Lieping Chen
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus.

Authors:  Laurie J Zoecklein; Kevin D Pavelko; Jeff Gamez; Louisa Papke; Dorian B McGavern; Daren R Ure; M Kariuki Njenga; Aaron J Johnson; Shunya Nakane; Moses Rodriguez
Journal:  Brain Pathol       Date:  2003-07       Impact factor: 6.508

5.  Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer.

Authors:  Nicholas C Souders; Duane A Sewell; Zhen-Kun Pan; S Farzana Hussain; Alexander Rodriguez; Anu Wallecha; Yvonne Paterson
Journal:  Cancer Immun       Date:  2007-02-06

6.  Influenza virus-infected epithelial cells present viral antigens to antigen-specific CD8+ cytotoxic T lymphocytes.

Authors:  H H Nguyen; P N Boyaka; Z Moldoveanu; M J Novak; H Kiyono; J R McGhee; J Mestecky
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 7.  Human papillomavirus infection with particular reference to genital disease.

Authors:  C Sonnex
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

8.  Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms.

Authors:  John M Routes; Kristin Morris; Misoo C Ellison; Sharon Ryan
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 9.  Immunotherapy and immunoescape in colorectal cancer.

Authors:  Guillermo Mazzolini; Oihana Murillo; Catalina Atorrasagasti; Juan Dubrot; Iñigo Tirapu; Miguel Rizzo; Ainhoa Arina; Carlos Alfaro; Arantza Azpilicueta; Carmen Berasain; José L Perez-Gracia; Alvaro Gonzalez; Ignacio Melero
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 10.  Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions.

Authors:  Shreya Kanodia; Diane M Da Silva; W Martin Kast
Journal:  Int J Cancer       Date:  2008-01-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.